NEOLISE Sculpt is a provider-prescribed peptide therapy built around tesamorelin — a GHRH-analog whose active ingredient is FDA-approved — delivered as a daily subcutaneous injection to target visceral (deep belly) fat while helping preserve lean muscle. Rather than a supplement, it is a compounded prescription product accessed via telehealth: the patient chooses a plan and completes a short (~5 minute) online health review, a US-licensed provider reviews it and prescribes if appropriate, and a licensed US 503A compounding pharmacy compounds it fresh monthly and cold-ships it, pre-mixed and ready to inject, to all 50 states with syringes and supplies included.

The product is aimed at adults over ~35 with stubborn visceral belly fat that resists diet and exercise, declining growth hormone, active/athletic people wanting recomposition, and current GLP-1 users who want to target visceral fat and protect muscle alongside their weight loss.

Benefits

Targets visceral fat specifically (up to 18% reduction vs 2% placebo over 26 weeks in trials).

Helps preserve — and may support — lean muscle mass (a contrast to GLP-1s).

Positioned as the "missing piece" for GLP-1 users seeking true recomposition.

Supports deeper, more restorative sleep (often reported in weeks 1–2).

Supports metabolic markers (triglycerides, insulin sensitivity, inflammation) and liver-fat reduction.

Works with the body's own hormonal feedback loops rather than injecting synthetic HGH.

How It Works

Online intake — a short (about three-minute) online health questionnaire.

Physician review — a US-licensed physician reviews the application and personalizes the dose.

Discreet delivery — if approved, a certified US compounding pharmacy ships the prescription in a plain, unmarked box.

Checkout event fires on order placement - non-payable

Conversion fires on shipment - payable

Payouts:

1 month - $80

3 months - $220

6 months - $380

12 months - $560

Creative materials: https://drive.google.com/drive/folders/1mp4Q66H5JvXxuthdmOAnSITMP87ViS-B?usp=sharing

Restrictions:

• US only, all 50 states

• No incentivized traffic

• No trademark or brand bidding on NEOLISE, Nexxana, or product names

• No disease claims, no "FDA approved," no guaranteed results, no specific weight loss numbers

• No before/after imagery

• No comparison to Ozempic, Wegovy, Mounjaro or any branded drug by name

• Desire is women 18+ only, no adult or dating placements

Mobidea